The medical device maker raised its full-year earnings forecast and projected 3.5%-4.5% revenue growth for 2026.
Teleflex updated its 2026 financial outlook, raising adjusted earnings per share guidance to a range of $6.90 to $7.20. The company also forecasted revenue growth of 3.5% to 4.5% for the year, reflecting recent operational performance.
In Q2 2026, the company reported 4.7% pro forma adjusted constant currency growth and a 19.6% adjusted operating margin. Management noted better-than-expected revenue and margins but acknowledged underperformance in its Interventional segment.
The revised outlook follows strong quarterly results, though challenges in specific business units may temper investor expectations.